Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity of Lupin's Pegfilgrastim vs Neulasta in Breast Cancer
NCT03511378Phase 4Completed
- Sponsor
- Lupin Limited
- Start
- Mar 2018
- Primary completion
- Jan 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 4 trial of pegfilgrastim in febrile neutropenia (FN), sponsored by Lupin Limited. Started Mar 2018; status: completed.
02
Drugs
pegfilgrastim
03
Conditions
febrile neutropenia (FN)
Beyond the preview
Go deeper on NCT03511378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03511378.